RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Ke Wu to No-Observed-Adverse-Effect Level

Back to Details
This is a "connection" page, showing publications Ke Wu has written about No-Observed-Adverse-Effect Level.
Ke Wu
Connection Strength
0.039
No-Observed-Adverse-Effect Level
  1. Liu CH, Chiu HC, Sung HL, Yeh JY, Wu KC, Liu SH. Acute oral toxicity and repeated dose 28-day oral toxicity studies of MIL-101 nanoparticles. Regul Toxicol Pharmacol. 2019 Oct; 107:104426.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support